These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 849650)

  • 1. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
    Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
    Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
    Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
    Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HLA and myasthenia. Subdivision in 3 categories].
    Elchidiac A; Lepage V; Berrih S; Colombani J; Degos L
    Pathol Biol (Paris); 1985 Jan; 33(1):50-4. PubMed ID: 3871932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
    Richman DP; Patrick J; Arnason BG
    N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens and myasthenia gravis in Japan.
    Yoshida T; Tsuchiya M; Ono A; Yoshimatsu H; Satoyoshi E; Tsuji K
    J Neurol Sci; 1977 Jun; 32(2):195-201. PubMed ID: 874518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies, histocompatibility antigens and testosterone in males with alcoholic liver cirrhosis.
    Gluud C; Tage-Jensen U; Bahnsen M; Dietrichson O; Svejgaard A
    Clin Exp Immunol; 1981 Apr; 44(1):31-7. PubMed ID: 6973433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological features of juvenile onset diabetic patients correlated to HLA type.
    Richens ER; Quilley J; Hartog M
    Clin Exp Immunol; 1979 May; 36(2):198-204. PubMed ID: 477024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
    Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
    Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
    [No Abstract]   [Full Text] [Related]  

  • 14. The association of HLA-B8 with visceral disease in systemic sclerosis.
    Hughes P; Gelsthorpe K; Doughty RW; Rowell NR; Rosenthal FD; Sneddon IB
    Clin Exp Immunol; 1978 Mar; 31(3):351-6. PubMed ID: 306903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
    Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
    Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new HLA-B antigen: HLA-Bw 59].
    Nakai Y
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):614-21. PubMed ID: 6210236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA in asthma.
    Morris MJ; Vaughan H; Lane DJ; Morris PJ
    Monogr Allergy; 1977; 11():30-4. PubMed ID: 876121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies in thymectomized and non-thymectomized patients with myasthenia gravis.
    Sørensen SF; Andersen V; Bendtzen K; Fulpius BW; Krarup C; Monnier VM; Permin H; Platz P; Søeberg B; Thomsen M
    J Clin Lab Immunol; 1978 Nov; 1(3):169-78. PubMed ID: 387958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.